CDKN2A and central nervous system cancer: Onco panel, offered by Diatech Pharmacogenetics (Jesi, Italy), has CE-IVD certification and covers 56 genes including usual glioma marker genes such as BRAF, CDKN2A, EGFR, IDH1, IDH2, NOTCH, and TP53 (Marchetti et al., 2021; Eurofins Genomics, 2023).